Φορτώνει......
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
OBJECTIVE: Analogues of GDF15 (Growth Differentiation Factor 15) are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and body weight. GDF15 exerts its central anorexic effects by binding to the GFRAL receptor exclusively expr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Metab |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6407365/ https://ncbi.nlm.nih.gov/pubmed/30685336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2019.01.003 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|